According to the Zhitong Finance App, Kingsley Biotech (01548.HK) announced that according to the cooperation and licensing agreement between Legend Biotech and Janssen Biotech, Inc. (Janssen) on December 21, 2017, CARVYKTI® generated net trade sales of approximately US$369 million for the quarter ended March 31, 2025.

Zhitongcaijing · 04/15 12:25
According to the Zhitong Finance App, Kingsley Biotech (01548.HK) announced that according to the cooperation and licensing agreement between Legend Biotech and Janssen Biotech, Inc. (Janssen) on December 21, 2017, CARVYKTI® generated net trade sales of approximately US$369 million for the quarter ended March 31, 2025.